Global Aurora Kinase B Protein Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Aurora Kinase B Protein Market Insights, Forecast to 2034
Aurora kinase B is a protein that functions in the attachment of the mitotic spindle to the centromere.
Global Aurora Kinase B Protein market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aurora Kinase B Protein industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Aurora Kinase B Protein key manufacturers include Sino Biological, Inc., Thermo Fisher Scientific (China) Co., Ltd., Elabscience Biotechnology Inc., OriGene Technologies, Inc., Cielo Therapeutics Inc, Sanofi, AbbVie Inc, Advenchen Laboratories LLC and Aeterna Zentaris Inc, etc. Sino Biological, Inc., Thermo Fisher Scientific (China) Co., Ltd., Elabscience Biotechnology Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Aurora Kinase B Protein were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Aurora Kinase B Protein market and estimated to attract more attentions from industry insiders and investors.
Aurora Kinase B Protein can be divided into AZD-2811, CS-2164 and Others,, etc. AZD-2811 is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Aurora Kinase B Protein is widely used in various fields, such as Hospital, Research Institute and Others,, etc. Hospital provides greatest supports to the Aurora Kinase B Protein industry development. In 2022, global % sales of Aurora Kinase B Protein went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Aurora Kinase B Protein market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Aurora Kinase B Protein market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

Sino Biological, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Elabscience Biotechnology Inc.
OriGene Technologies, Inc.
Cielo Therapeutics Inc
Sanofi
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca PIc
Chipscreen Biosciences Ltd
Segment by Type
AZD-2811
CS-2164
Others
Hospital
Research Institute
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Aurora Kinase B Protein plant distribution, commercial date of Aurora Kinase B Protein, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Aurora Kinase B Protein introduction, etc. Aurora Kinase B Protein Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Aurora Kinase B Protein
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Aurora Kinase B Protein market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aurora Kinase B Protein industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Aurora Kinase B Protein key manufacturers include Sino Biological, Inc., Thermo Fisher Scientific (China) Co., Ltd., Elabscience Biotechnology Inc., OriGene Technologies, Inc., Cielo Therapeutics Inc, Sanofi, AbbVie Inc, Advenchen Laboratories LLC and Aeterna Zentaris Inc, etc. Sino Biological, Inc., Thermo Fisher Scientific (China) Co., Ltd., Elabscience Biotechnology Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Aurora Kinase B Protein were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Aurora Kinase B Protein market and estimated to attract more attentions from industry insiders and investors.
Aurora Kinase B Protein can be divided into AZD-2811, CS-2164 and Others,, etc. AZD-2811 is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Aurora Kinase B Protein is widely used in various fields, such as Hospital, Research Institute and Others,, etc. Hospital provides greatest supports to the Aurora Kinase B Protein industry development. In 2022, global % sales of Aurora Kinase B Protein went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Aurora Kinase B Protein market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Aurora Kinase B Protein market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Sino Biological, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Elabscience Biotechnology Inc.
OriGene Technologies, Inc.
Cielo Therapeutics Inc
Sanofi
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca PIc
Chipscreen Biosciences Ltd
Segment by Type
AZD-2811
CS-2164
Others
Segment by Application
Hospital
Research Institute
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Aurora Kinase B Protein plant distribution, commercial date of Aurora Kinase B Protein, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Aurora Kinase B Protein introduction, etc. Aurora Kinase B Protein Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Aurora Kinase B Protein
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
